Literature DB >> 21842258

Stem cell therapy for incontinence: where are we now? What is the realistic potential?

Charuspong Dissaranan1, Michelle A Cruz, Bruna M Couri, Howard B Goldman, Margot S Damaser.   

Abstract

A significant number of women experience stress urinary incontinence (SUI), which greatly affects their quality of life. Recent research investigating utilization of stem cells and their derivatives for the prevention and treatment of SUI has been performed to test the effect of cell source and method of administration in several animal models of SUI. The type of stem cell, timing of optimal dose or doses after injury, mechanism of action of stem cells, and route of administration must be investigated both preclinically and clinically before stem cell therapy becomes a possible treatment for SUI, although the future of this therapy looks promising. This article reviews the progress in stem cell research for incontinence and describes areas of future work as suggested by research in other fields. © Springer Science+Business Media, LLC 2011

Entities:  

Mesh：

Year:  2011        PMID： 21842258      PMCID： PMC3218558          DOI： 10.1007/s11934-011-0210-4

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


  86 in total

1.  Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractility.

Authors:  M B Chancellor; T Yokoyama; S Tirney; C E Mattes; H Ozawa; N Yoshimura; W C de Groat; J Huard
Journal:  Neurourol Urodyn       Date:  2000       Impact factor: 2.696

Review 2.  Stem cell therapy for stress urinary incontinence.

Authors:  Dmitriy Nikolavsky; Michael B Chancellor
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

3.  Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.

Authors:  Susanne Kern; Hermann Eichler; Johannes Stoeve; Harald Klüter; Karen Bieback
Journal:  Stem Cells       Date:  2006-01-12       Impact factor: 6.277

4.  Culture and characterization of human bone marrow mesenchymal stem cells.

Authors:  Bruno Delorme; Pierre Charbord
Journal:  Methods Mol Med       Date:  2007

5.  Angiogenic gene-modified muscle cells for enhancement of tissue formation.

Authors:  Paolo De Coppi; Dawn Delo; Lynn Farrugia; Kavid Udompanyanan; James J Yoo; Masashi Nomi; Anthony Atala; Shay Soker
Journal:  Tissue Eng       Date:  2005 Jul-Aug

6.  LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.

Authors:  Jay H Traverse; Timothy D Henry; Douglas E Vaughan; Stephen G Ellis; Carl J Pepine; James T Willerson; David X M Zhao; Lara M Simpson; Marc S Penn; Barry J Byrne; Emerson C Perin; Adrian P Gee; Antonis K Hatzopoulos; David H McKenna; John R Forder; Doris A Taylor; Christopher R Cogle; Sarah Baraniuk; Rachel E Olson; Beth C Jorgenson; Shelly L Sayre; Rachel W Vojvodic; David J Gordon; Sonia I Skarlatos; Lemuel A Moyè; Robert D Simari
Journal:  Tex Heart Inst J       Date:  2010

7.  Human cord blood stem cell therapy for treatment of stress urinary incontinence.

Authors:  Chung No Lee; Jin Beum Jang; Ji Young Kim; Chester Koh; Jin Young Baek; Kyoung Jin Lee
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

8.  Embryonic stem cells can form germ cells in vitro.

Authors:  Yayoi Toyooka; Naoki Tsunekawa; Ryuko Akasu; Toshiaki Noce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

9.  Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells.

Authors:  Jalees Rehman; Dmitry Traktuev; Jingling Li; Stephanie Merfeld-Clauss; Constance J Temm-Grove; Jason E Bovenkerk; Carrie L Pell; Brian H Johnstone; Robert V Considine; Keith L March
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

10.  Primary cultures from rat vibrissae as a potential cell source for in vitro construction of urinary bladder wall grafts.

Authors:  T Drewa; R Joachimiak; A Kaznica; V Sarafian; J Sir
Journal:  Transplant Proc       Date:  2009-06       Impact factor: 1.066
View more
  7 in total

1.  Impact of parturition on chemokine homing factor expression in the vaginal distention model of stress urinary incontinence.

Authors:  Andrew T Lenis; Mei Kuang; Lynn L Woo; Adonis Hijaz; Marc S Penn; Robert S Butler; Raymond Rackley; Margot S Damaser; Hadley M Wood
Journal:  J Urol       Date:  2012-09-25       Impact factor: 7.450

Review 2.  Virus integration and genome influence in approaches to stem cell based therapy for andro-urology.

Authors:  Longkun Li; Deying Zhang; Peng Li; Margot Damaser; Yuanyuan Zhang
Journal:  Adv Drug Deliv Rev       Date:  2014-10-18       Impact factor: 15.470

3.  The effects of microenergy acoustic pulses on animal model of obesity-associated stress urinary incontinence. Part 2: In situ activation of pelvic floor and urethral striated muscle progenitor cells.

Authors:  Ning Kang; Dongyi Peng; Bohan Wang; Yajun Ruan; Jun Zhou; Amanda B Reed-Maldonado; Lia Banie; Guifang Wang; Nianzeng Xing; Yuxin Tang; Guiting Lin; Tom F Lue
Journal:  Neurourol Urodyn       Date:  2019-08-27       Impact factor: 2.696

4.  Rat mesenchymal stem cell secretome promotes elastogenesis and facilitates recovery from simulated childbirth injury.

Authors:  Charuspong Dissaranan; Michelle A Cruz; Matthew J Kiedrowski; Brian M Balog; Bradley C Gill; Marc S Penn; Howard B Goldman; Margot S Damaser
Journal:  Cell Transplant       Date:  2013-07-17       Impact factor: 4.064

Review 5.  Towards a Treatment of Stress Urinary Incontinence: Application of Mesenchymal Stromal Cells for Regeneration of the Sphincter Muscle.

Authors:  Wilhelm K Aicher; Melanie L Hart; Jan Stallkamp; Mario Klünder; Michael Ederer; Oliver Sawodny; Martin Vaegler; Bastian Amend; Karl D Sievert; Arnulf Stenzl
Journal:  J Clin Med       Date:  2014-02-24       Impact factor: 4.241

Review 6.  Treatment of bladder dysfunction using stem cell or tissue engineering technique.

Authors:  Jae Heon Kim; Hong Jun Lee; Yun Seob Song
Journal:  Korean J Urol       Date:  2014-04-10

7.  Small activating RNA induces myogenic differentiation of rat adipose-derived stem cells by upregulating MyoD.

Authors:  Chenghe Wang; Zhong Chen; Jia Wu; Yan Zhang; Jia Hu; Qiangqiang Ge; Weimin Yang; Hua Xu; Jihong Liu; Zhangqun Ye
Journal:  Int Braz J Urol       Date:  2015 Jul-Aug       Impact factor: 1.541
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.